首页>投融资

Pheon

B轮

Pheon Therapeutics, formerly known as Femtogenix, founded as a spin-out company of King's College London and Research Corporation Technologies (RCT), is focused on developing antibody drug conjugates (ADCs) for the potential treatment of cancer.In August 2022, the company changed its name from Femtogenix Ltd to Pheon Therapeutics.In July 2023, Pheon Therapeutics entered into exclusive licence agreement with Biocytogen Pharmaceuticals to develop and commercialize an antibody.In September 2022, the company announced the closing of a USD 68 million Series A financing in March 2022. The financing was led by Brandon Capital, Forbion and Atlas Venture, with participation from seed investor Research Corporation Technologies (RCT).In October 2015, Research Corporation Technologies (RCT) provided the initial series A investment to the company

http://www.femtogenix.com/

470210

基本信息

公司全称

Pheon Therapeutics Ltd
类型

抗体偶联药物（ADC）研发商
产业领域

医药研发/制造、化学&生物药
公司人数

15人以下
地址

Lawes Open Innovation Hub Rothamsted Research West Common HARPENDEN HERTFORDSHIRE AL5; GB; Telephone: +442037951919;
联系电话

442037951919
邮箱

info@pheontx.com
成立时间

2022-01-01

投融资

2024-05-21

B轮

1.2亿美元

BVF Partners

Lightspeed Venture Partners

Perceptive Advisors

Atlas Venture

Brandon Capital Partners

Forbion Capital Partners

Research Corporation Technologies
2022-09-28

A轮

6800万美元

Forbion Capital Partners

Atlas Venture

Brandon Capital Partners

Research Corporation Technologies

Pheon

基本信息

投融资

相关投融资企业